ArticleHuman vaccines & immunotherapeutics2021

B16 melanoma control by anti-PD-L1 requires CD8+ T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines.

Sunhee Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.